Total Hip Arthroplasty Using Small Direct Anterior Incision: The Role of Short Femoral Stem

Status unconfirmed · Not applicable

Conditions studied: Total Hip Arthroplasty

In brief

This study aims to investigate short-term outcomes following the use of two femoral stems used during Total Hip arthoplasty: the Fitmore Femoral stem and the M/L Taper Femoral stem.

Key facts

Study ID

NCT01614028

Run by

Rothman Institute Orthopaedics

Last updated by the study team

2013-04-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient signed an IRB, study specific informed patient consent.
• Patient is a male or non-pregnant female age 18 years or older at the time of study device implantation.
• Patient has primary diagnosis of non-inflammatory degenerative joint disease.
• Patient is a candidate for primary cementless total hip replacement.
• Patient is willing and able to comply with postoperative scheduled clinical and radiographic evaluations and rehabilitation.

You may not qualify if…

• Patient has a Body Mass Index (BMI) > 40 Kg/m2.
• Patient has an active or suspected infection at the time of device implantation.
• Patient is immunologically suppressed.
• Patient requires revision surgery of a previously implanted total hip replacement.
• Patient has a known sensitivity to device materials.

Where it is running

• Rothman Institute at AtlantiCare — Egg Harbor, New Jersey, United States (enrolling)
• Rothman Institute at Thomas Jefferson University — Philadelphia, Pennsylvania, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.